#3 - “The Phone Works for Some Youth….” a Mixed Methods Evaluation of Patient Satisfaction With In-Person and Phone Delivery of the Adolescent Transition Package in Kenya During the COVID-19 Pandemic

International Workshop on Adolescence, SRHR, & HIV 2024

#2 - Using Technology to Reach Adolescents and Young People (AYP) in Sub-Saharan Africa With SRH and HIV Services: The Case of the Tiko Platform

International Workshop on Adolescence, SRHR, & HIV 2024

#1 - Pilot Evaluation of Digital MindSKILLZ in Lagos, Nigeria: An Interactive Voice Response Game to Improve Mental Wellbeing of Adolescents

International Workshop on Adolescence, SRHR, & HIV 2024

Digital Innovations for Adolescent Health: Balancing Aspirations and Evidence-based Realities

International Workshop on Adolescence, SRHR, & HIV 2024

Adolescent HIV and SRHR - Insights from 40 Years of Research and Implementation

International Workshop on Adolescence, SRHR, & HIV 2024

Modelling Design and Validations for Complex LA Medicines | Simone Perazzolo

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024

Evolution of Long-Acting ARVs | Charles Flexner

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024

The Evolution of Antiretroviral Tissue Pharmacokinetics | Angela DM Kashuba

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024

Therapeutic Drug Monitoring of Antiretrovirals – Is There a Future? | David Burger

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024

The History of Pharmacology at the University of Liverpool | David Back

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024

Case 2: Substituting Statins – Same or Different? | Thomas Heseltine

The Liverpool Course 2024

Dolutegravir with TB Treatment, How Low is Too Low? | Geraint Rhys Davies

The Liverpool Course 2024

Case 1: Gender Transitioning with ARVs | Tessa Senneker

The Liverpool Course 2024

Case Presentation 2: HepB/HepD Cirrhosis in a Patient Living with HIV_Stefan Cristian Malciolu

Central and Eastern European Meeting on Viral Hepatitis and HIV 2024

State-of-the-Art: Hepatitis B and D in People Living with HIV_Mojca Matičič

Central and Eastern European Meeting on Viral Hepatitis and HIV 2024

Case Presentation 1: Long Acting ART as Maintenance Therapy in People Living with HIV_David Jilich

Central and Eastern European Meeting on Viral Hepatitis and HIV 2024

The Future of Long-acting ARV for HIV Prevention and Treatment in Europe_Jürgen Rockstroh

Central and Eastern European Meeting on Viral Hepatitis and HIV 2024

Advances in PrEP: What Has Been Achieved? Which Challenges Remain?_Anca Streinu-Cercel

Central and Eastern European Meeting on Viral Hepatitis and HIV 2024

Update on the Epidemiology of HIV and Hepatitis in Central and Eastern Europe_Deniz Gökengin

Central and Eastern European Meeting on Viral Hepatitis and HIV 2024

Transition of Youth Living With HIV to Adult Care: Low-Resource Country Experience - Anthony Enimil

International Workshop on Pediatrics & HIV 2024

Transition of Youth Living With HIV to Adult Care: High-Resource Country Experience - Caroline Foster

International Workshop on Pediatrics & HIV 2024

Effectiveness and Safety of Tenofovir Alafenamide Fumarate (TAF)-Based Therapy Compared to Tenofovir Disoproxil Fumarate (TDF)- And Abacavir (ABC)-Based Therapy in Children and Adolescents Living With HIV (CALHIV) (...) - Elizabeth Chappell

International Workshop on Pediatrics & HIV 2024

#19 - Adolescents and Young Adults with HIV Using Long-Acting Injectable Cabotegravir/Rilpivirine as a Standard of Care: Outcomes of the Observational Cohort at 26 months - Tierra Williams

International Workshop on Pediatrics & HIV 2024

#18 - Concerning Lack of Virological Suppression in Plasma and Cerebrospinal Fluid in Adolescents on Long-term Early Antiretroviral Therapy - Barbara Laughton

International Workshop on Pediatrics & HIV 2024